Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-10.81	87.03	97.58
Graham Fair Price	-53.98	2.20	4.79
PEG	71.94	1.50	-0.87
Price/Book	-10.44	4.61	5.14
Price/Cash Flow	58623.32	-89776.58	152.88
Prices/Earnings	318.31	-182.96	43.74
Price/Sales	-5.40	21.64	22.88
Price/FCF	58623.32	-89776.58	152.88
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-2.37	0.51	0.52
Operating Margin	11.81	0.16	0.14
ROA	-78.91	< 0.005	0.02
ROE	0.03	< 0.005	-78.59
ROIC	0.02	-0.01	-52.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	10.05	-99.96
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.50	0.05	-88.95
EPS QOQ	-0.50	-1.22	-143.29
FCF QOQ	1.46	-1.00	-31.20
Revenue QOQ	-0.07	-0.06	24.18
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	122.98	124.52	1.25
Days Sales Outstanding (DSO)	41.73	46.82	12.21
Inventory Turnover	0.73	0.72	-1.24
Debt/Capitalization	0.20	0.19	-4.88
Quick Ratio	2.77	2.95	6.47
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.89	5.85	-0.55
Cash	1.11	1.15	3.44
Capex	-0.18	-0.07	58.60
Free Cash Flow	0.20	< 0.005	-99.85
Revenue	1.32	1.25	-5.85
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.57	4.85	6.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.02	0.88	-14.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating